Published in Nat Rev Cardiol on April 12, 2011
Microbial Evaluation of Denture Cleaning and Overnight Storage | NCT02454413
Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res (2013) 2.89
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Intruders below the radar: molecular pathogenesis of Bartonella spp. Clin Microbiol Rev (2012) 1.33
Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J (2013) 1.24
PCR-electrospray ionization mass spectrometry for direct detection of pathogens and antimicrobial resistance from heart valves in patients with infective endocarditis. J Clin Microbiol (2013) 1.00
Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunol Res (2014) 0.95
Role of the serine-rich surface glycoprotein Srr1 of Streptococcus agalactiae in the pathogenesis of infective endocarditis. PLoS One (2013) 0.92
Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr Cardiol Rep (2014) 0.88
A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One (2013) 0.88
Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun (2012) 0.87
Nontraumatic splenic emergencies: cross-sectional imaging findings and triage. Emerg Radiol (2013) 0.85
Dissemination of periodontal pathogens in the bloodstream after periodontal procedures: a systematic review. PLoS One (2014) 0.84
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE). Infect Dis Ther (2015) 0.84
Molecular characterization of endocarditis-associated Staphylococcus aureus. J Clin Microbiol (2013) 0.81
SmbFT, a putative ABC transporter complex, confers protection against the lantibiotic Smb in Streptococci. J Bacteriol (2013) 0.81
Epidemiology and the prognosis of healthcare-associated infective endocarditis in China: the significance of non-nosocomial acquisition. Emerg Microbes Infect (2015) 0.80
Modification of Streptococcus mutans Cnm by PgfS contributes to adhesion, endothelial cell invasion, and virulence. J Bacteriol (2014) 0.80
Evidence for steric regulation of fibrinogen binding to Staphylococcus aureus fibronectin-binding protein A (FnBPA). J Biol Chem (2014) 0.79
Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis (2014) 0.79
Advantages and Limitations of Direct PCR Amplification of Bacterial 16S-rDNA from Resected Heart Tissue or Swabs Followed by Direct Sequencing for Diagnosing Infective Endocarditis: A Retrospective Analysis in the Routine Clinical Setting. Biomed Res Int (2016) 0.79
Functional analysis of an unusual type IV pilus in the Gram-positive Streptococcus sanguinis. Mol Microbiol (2015) 0.78
Small Molecule Inhibitors Limit Endothelial Cell Invasion by Staphylococcus aureus. Curr Pharm Biotechnol (2014) 0.78
Cloning-independent markerless gene editing in Streptococcus sanguinis: novel insights in type IV pilus biology. Nucleic Acids Res (2016) 0.77
Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3. Platelets (2016) 0.77
Dental Procedures and the Risk of Infective Endocarditis. Medicine (Baltimore) (2015) 0.77
Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging (2011) 0.77
Phylogenomic and MALDI-TOF MS analysis of Streptococcus sinensis HKU4T reveals a distinct phylogenetic clade in the genus Streptococcus. Genome Biol Evol (2014) 0.77
Clinical presentation of infective endocarditis caused by different groups of non-beta haemolytic streptococci. Eur J Clin Microbiol Infect Dis (2015) 0.77
Getting to the heart of the matter: Role of Streptococcus mutans adhesin Cnm in systemic disease. Virulence (2016) 0.76
Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data. Ther Adv Infect Dis (2017) 0.75
Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities. MBio (2017) 0.75
Infective endocarditis involving an apparently structurally normal valve: new epidemiological trend? Korean J Intern Med (2015) 0.75
The prognosis of infective endocarditis treated with biological valves versus mechanical valves: A meta-analysis. PLoS One (2017) 0.75
Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study. Medicine (Baltimore) (2016) 0.75
Fever and multiorgan infarcts in a 35-year-old man. CMAJ (2012) 0.75
Cerebral infarction caused by a heart-breaking needle: a case report. J Med Case Rep (2016) 0.75
Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii. Infect Immun (2016) 0.75
An observational study on infective endocarditis: a single center experience. Res Cardiovasc Med (2014) 0.75
The Collagen Binding Proteins of Streptococcus mutans and Related Streptococci. Mol Oral Microbiol (2016) 0.75
Intracranial Aneurysms From Presumed Infective Endocarditis: The Dilemma of Persistently Negative Cultures. Neurohospitalist (2015) 0.75
Streptococcus sanguinis induces neutrophil cell death by production of hydrogen peroxide. PLoS One (2017) 0.75
Bacteria endocarditis consolidation with vertebra bone tuberculosis: a case report. BMC Infect Dis (2017) 0.75
A rare case of fungal endocarditis caused by Candida glabrata after completion of antibiotic therapy for Streptococcus endocarditis. J Med Ultrason (2001) (2014) 0.75
Draft Genome Sequence of a Clinical Isolate of Streptococcus mutans Strain HM. Genome Announc (2017) 0.75
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med (2005) 1.85
Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans. Appl Environ Microbiol (2008) 1.58
The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett (2006) 1.29
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. Int J Antimicrob Agents (2010) 1.26
Granular layer in the periplasmic space of gram-positive bacteria and fine structures of Enterococcus gallinarum and Streptococcus gordonii septa revealed by cryo-electron microscopy of vitreous sections. J Bacteriol (2006) 1.19
Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care (2010) 1.18
Innate sensors for Gram-positive bacteria. Curr Opin Immunol (2003) 1.15
Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infect Immun (2005) 1.12
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis (2009) 1.09
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (2012) 1.08
Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. FEMS Microbiol Lett (2012) 1.06
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother (2003) 1.06
The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect Immun (2008) 1.05
Staphylococcus aureus host range and human-bovine host shift. Appl Environ Microbiol (2011) 1.04
Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol (2005) 1.03
Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun (2005) 1.02
Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics (2007) 1.01
Ecological temporal stability of Staphylococcus aureus nasal carriage. J Clin Microbiol (2010) 1.00
ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Mol Cell Proteomics (2007) 0.98
Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis (2011) 0.98
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA (2011) 0.97
Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs. Appl Environ Microbiol (2012) 0.97
Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrob Agents Chemother (2006) 0.96
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. J Antimicrob Chemother (2006) 0.95
Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thromb Haemost (2007) 0.94
Mutations in penicillin-binding protein (PBP) genes and in non-PBP genes during selection of penicillin-resistant Streptococcus gordonii. Antimicrob Agents Chemother (2006) 0.93
Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii. Antimicrob Agents Chemother (2006) 0.92
Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis. Int J Med Microbiol (2013) 0.92
New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep (2006) 0.92
M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. BMC Genomics (2009) 0.91
Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir (2010) 0.91
Prospective determination of plasma imipenem concentrations in critically ill children. Antimicrob Agents Chemother (2006) 0.90
Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J Pharm Biomed Anal (2002) 0.90
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2004) 0.88
A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. Int J Antimicrob Agents (2011) 0.88
Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infect Immun (2010) 0.87
Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing Swiss and French isolates from the Rhône Valley. Appl Environ Microbiol (2011) 0.87
Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Mol Cell Proteomics (2012) 0.87
Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun (2012) 0.87
Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome. PLoS One (2013) 0.86
Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro. Antimicrob Agents Chemother (2002) 0.86
Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin. Antimicrob Agents Chemother (2010) 0.85
Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis. Microb Pathog (2008) 0.84
Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii. Microbiology (2007) 0.83
Genometrics as an essential tool for the assembly of whole genome sequences: the example of the chromosome of Bifidobacterium longum NCC2705. BMC Microbiol (2005) 0.83
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrob Agents Chemother (2004) 0.83
Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii. Antimicrob Agents Chemother (2007) 0.81
In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother (2013) 0.81
Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. Thromb Haemost (2009) 0.81
Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrob Agents Chemother (2005) 0.80
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. J Antimicrob Chemother (2007) 0.79
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis. FEMS Immunol Med Microbiol (2006) 0.79
Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. J Med Microbiol (2007) 0.79
PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express (2011) 0.77
Combining protein identification and quantification: C-terminal isotope-coded tagging using sulfanilic acid. Rapid Commun Mass Spectrom (2006) 0.77
Evidence for a new post-translational modification in Staphylococcus aureus: hydroxymethylation of asparagine and glutamine. J Proteomics (2011) 0.77
Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory. Antimicrob Agents Chemother (2007) 0.75
Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. Int J Antimicrob Agents (2013) 0.75
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. Antimicrob Agents Chemother (2009) 0.75
[Infective endocarditis: update]. Rev Med Suisse Romande (2004) 0.75
Daptomycin for highly resistant Enterococcus faecium infection. Swiss Med Wkly (2012) 0.75